MultiMedica
In research, MultiMedica stands highest in Medicine (#1,686 of 10,443 worldwide) and Health Sciences (#2,297 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Cardiology and Cardiovascular Medicine — Cardiology and Cardiovascular Medicine is 15.2× its share of world research.
- World rank, 2022–2025
- #4,956 of 28,054 · #5,686 all time
- Rank in Italy
- #137 of 618
- Research works
- 1.7k ▲ 52% vs 2013–17
- Citations
- 41k 24.3 per fractional work
- Top-10% rate
- 23.3% record average 16.5%
- Open access
- 40% world 28%
What is MultiMedica known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,686 of 10,443 | 23.4% | 260 | #2095 | |
| Health SciencesDomain | #2,297 of 11,982 | 23.2% | 272 | #2696 |
Each strip is that field’s whole ranked pool, with the notch where MultiMedica sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does MultiMedica specialise in?
Where its research is concentrated relative to its size: Cardiology and Cardiovascular Medicine takes 15.2× the share of its output that it takes of world research.
- Cardiology and Cardiovascular MedicineSubfield · 56.7 works15×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
- Medicine 3.8×
- Immunology and Microbiology 2.8×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Nursing 1.1×
- Neuroscience 1.0×
- Health Professions 0.9×
- Dentistry 0.8×
- Economics, Econometrics and Finance 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Psychology 0.3×
- Decision Sciences 0.2×
- Environmental Science 0.2×
- Mathematics 0.2×
- Energy 0.1×
- Chemistry 0.1×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Materials Science 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Chemical Engineering 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at MultiMedica?
Ranked on the composite score, Antonio Ceriello, Caterina Conte and Silvio Bertoli lead among researchers whose main affiliation is MultiMedica.
- 1 Antonio Ceriello · #10,381 worldwide 921 citations · 99 works
- 2 Caterina Conte · #154,051 worldwide 276 citations · 20 works
- 3 Silvio Bertoli · #178,196 worldwide 113 citations · 27 works
- 4 J. H. Laragh · #342,067 worldwide 74 citations · 19 works
- 5 Antonio E. Pontiroli · #435,848 worldwide 60 citations · 21 works
- 6 Adriana Albini · #460,147 worldwide 160 citations · 67 works
- 7 Edoardo Gronda · #460,157 worldwide 52 citations · 34 works
- 8 Sergio Harari · #470,709 worldwide 68 citations · 39 works
- 9 Annibale Alessandro Puca · #481,608 worldwide 110 citations · 23 works
- 10 Douglas M. Noonan · #493,899 worldwide 123 citations · 45 works
Which keywords describe research at MultiMedica?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cardiovascular Disease, Obesity, Metabolic Syndrome, Inflammation, Clinical Trials, C-Reactive Protein, Statins and Heart Failure.
- Macular Degeneration
- Adipose Tissue
- Insulin Therapy
- Atrial Fibrillation
- Lifestyle Intervention
- Clinical Guidelines
- Glucose Metabolism
- Chamber Quantification
- Complications
- Guidelines
- Risk Factors
- Cardiovascular Risk
- Echocardiography
- Cholesterol-lowering
- Cardiovascular Disease Prevention
- Atherosclerosis
- Statins
- Clinical Trials
- Metabolic Syndrome
- Cardiovascular Disease
- Inflammation
- Obesity
- Epidemiology
- C-Reactive Protein
- Heart Failure
- Insulin Resistance
- Genetic Variants
- LDL Cholesterol
- Diabetes
- Oxidative Stress
- Cholesterol
- Myocardial Infarction
- Type 2 Diabetes
- Diastolic Function
- Catheter Ablation
- Global Prevalence
- Glycemic Control
- Coronary Artery Disease
- Stroke Prevention
- Arrhythmias
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation36▲ 4.8×58 topics
- Cardiovascular Disease32▲ 8.1×32 topics
- Obesity31▲ 12×17 topics
- Metabolic Syndrome30▲ 11×20 topics
- Epidemiology29▲ 2.1×75 topics
- Clinical Trials22▲ 9.2×14 topics
- C-Reactive Protein21▲ 81×2 topics
- Statins21▲ 80×2 topics
- Heart Failure21▲ 13×14 topics
- Atherosclerosis20▲ 20×9 topics
- Insulin Resistance19▲ 12×10 topics
- Cardiovascular Disease Prevention19▲ 61×3 topics
- Genetic Variants18▲ 29×3 topics
- Cholesterol-lowering17▲ 107×1 topic
- LDL Cholesterol17▲ 139×1 topic
- Echocardiography16▲ 16×7 topics
- Diabetes14▲ 8.1×16 topics
- Cardiovascular Risk14▲ 12×8 topics
- Oxidative Stress13▲ 2.2×34 topics
- Risk Factors12▲ 3.2×21 topics
- Cholesterol12▲ 24×3 topics
- Guidelines11▲ 6.8×10 topics
- Myocardial Infarction11▲ 13×6 topics
- Complications10▲ 5.7×15 topics
- Type 2 Diabetes10▲ 13×6 topics
- Chamber Quantification9▲ 34×1 topic
- Diastolic Function9▲ 34×1 topic
- Glucose Metabolism9▲ 25×2 topics
- Catheter Ablation8▲ 20×2 topics
- Clinical Guidelines8▲ 8.0×9 topics
- Global Prevalence8▲ 25×2 topics
- Lifestyle Intervention8▲ 26×2 topics
- Glycemic Control7▲ 13×4 topics
- Atrial Fibrillation7▲ 20×2 topics
- Coronary Artery Disease7▲ 17×3 topics
- Insulin Therapy7▲ 16×3 topics
- Stroke Prevention7▲ 16×2 topics
- Adipose Tissue7▲ 36×2 topics
- Arrhythmias7▲ 20×2 topics
- Macular Degeneration6▲ 15×3 topics
Which research topics does MultiMedica publish most on?
By volume in 2022–2025: Lipoproteins and Cardiovascular Health, Cardiovascular Function and Risk Factors, Diabetes, Cardiovascular Risks, and Lipoproteins and Atrial Fibrillation Management and Outcomes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lipoproteins and Cardiovascular HealthSurgery 17 works
- 2 Cardiovascular Function and Risk FactorsCardiology and Cardiovascular Medicine 9 works
- 3 Diabetes, Cardiovascular Risks, and LipoproteinsEndocrinology, Diabetes and Metabolism 7 works
- 4 Atrial Fibrillation Management and OutcomesCardiology and Cardiovascular Medicine 5 works
- 5 Cardiac Health and Mental HealthCardiology and Cardiovascular Medicine 5 works
- 6 Adipokines, Inflammation, and Metabolic DiseasesEpidemiology 4 works
- 7 Orthopedic Surgery and RehabilitationSurgery 4 works
- 8 Diet and metabolism studiesPhysiology 4 works
- 9 Cardiovascular Disease and AdiposityCardiology and Cardiovascular Medicine 4 works
- 10 Cardiac Arrhythmias and TreatmentsCardiology and Cardiovascular Medicine 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has MultiMedica's research output changed?
Output in 2018–2022 was 52% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Milan
- University of Milan
- Politecnico di Milano
- Università Cattolica del Sacro Cuore
- University of Milano-Bicocca
- Vita-Salute San Raffaele University
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Fondazione IRCCS Istituto Nazionale dei Tumori
- Mario Negri Institute for Pharmacological Research
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.